Your trusted destination for CME, CPD & Medical Education across the Middle East.
IFCSCRM-26 offers an educational platform focused on emerging developments in cardiac stem cell therapy and regenerative medicine. The program provides insights into cell-based therapies, myocardial repair, tissue regeneration, translational research, and innovative approaches to cardiovascular care.
The International Forum on Cardiac Stem Cell Therapy and Regenerative Medicine (IFCSCRM-26) provides a specialized platform for cardiologists, researchers, stem cell scientists, biomedical professionals, and healthcare experts to explore emerging advances in cardiac regeneration. The forum focuses on innovative approaches involving stem cell therapy, tissue regeneration, cellular therapies, and regenerative strategies for cardiovascular conditions. Key discussions may include cardiac repair, myocardial regeneration, cell-based therapies, tissue engineering, biomaterials, and emerging regenerative technologies. Participants will have opportunities to review current research, clinical developments, translational approaches, and challenges associated with regenerative cardiovascular medicine. The scientific program encourages collaboration among clinicians, researchers, academic institutions, biotechnology organizations, and healthcare stakeholders. Through expert presentations, scientific sessions, and interactive discussions, IFCSCRM-26 aims to facilitate knowledge exchange and advance research in cardiac regenerative medicine.
New techniques and cell types being investigated for treating heart disease.
Newer methods designed to improve targeted delivery and retention of therapeutic cells in the heart.
Emerging treatment approaches, including effectiveness and safety of different cell types.
How regenerative strategies may help repair damaged heart tissue.
Cellular signaling and biological processes involved in heart repair.
How biomarkers may help predict treatment response and monitor cardiovascular regeneration.
Moving discoveries from laboratory and preclinical research toward clinical applications.
Evidence from clinical trials, treatment outcomes, challenges, and future research directions.
How genetic, environmental, and lifestyle factors contribute to individualized cardiovascular treatments.
Patient consent, ethical considerations, and responsible development of stem-cell therapies.
Navigating regulatory issues in the development of regenerative treatments.
Emerging trends and potential breakthroughs in cardiovascular regenerative medicine.
Accredited by the Saudi Commission for Health Specialties (SCFHS) for 1 CME hour.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow